Literature DB >> 80155

Hyperpigmentation after bleomycin therapy. Ultrastructural study.

H Perrot, J P Ortonne.   

Abstract

Pigmentation in a Causasian male, resulting from bleomycin therapy for Hodgkin's disease, has been studied ultrastructurally. The melanocytes, though present in normal numbers, showed several abnormalities; the endoplasmic reticulum and the Golgi apparatus were were well developed and the mitochondria were enlarged. Lipid inclusions in the endoplasmic reticulum and numerous autophagocytic vacuoles, some containing lipids were observed. Transfer of melanosomes to keratinocytes appeared to be increased. The melanosomes, which measured less than 0.55 mu were dispersed in the cytoplasm and did not form complexes, as has been observed with nitrogen mustard. The increase of melanocytic activity and the disturbance of melanosome transfer are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80155     DOI: 10.1007/BF00455292

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  27 in total

1.  Pathogenesis of diffuse melanosis secondary to malignant melanoma.

Authors:  K Konrad; K Wolff
Journal:  Br J Dermatol       Date:  1974-12       Impact factor: 9.302

2.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

3.  Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.

Authors:  M B Mosher; R C DeConti; J R Bertino
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

4.  Bleomycin (NSC-125066): phase I clinical study.

Authors:  R W Sonntag
Journal:  Cancer Chemother Rep       Date:  1972-04

5.  Inhibition of ligase reaction by bleomycin.

Authors:  M Miyaki; T Ono; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1971-09       Impact factor: 2.649

6.  Ultrastructure study on the alteration in the keratinocytes after TMP application and UV exposure.

Authors:  K Toda; M A Pathak; T B Fitzpatrick
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1973

7.  Experimental pigment donation in vivo.

Authors:  K Wolff; K Jimbow; T B Fitzpatrick
Journal:  J Ultrastruct Res       Date:  1974-06

8.  Bleomycin and other antitumor antibiotics of high molecular weight.

Authors:  H Umezawa
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea].

Authors:  P Frost; V T DeVita
Journal:  Arch Dermatol       Date:  1966-09

10.  Bleomycin: effects upon mammalian epidermal DNA synthesis.

Authors:  M E Gilmartin; S Epner; L Lasky; I M Freedberg
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

View more
  1 in total

1.  Bleomycin-induced flagellate dermatitis.

Authors:  Rachel Grynszpan; João Paulo Niemeyer-Corbellini; Marien Siqueira Soto Lopes; Marcia Ramos-e-Silva
Journal:  BMJ Case Rep       Date:  2013-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.